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Abstract Pelvic organ prolapse (POP) and urinary tract
infection (UTI) are important problems, estimated to af-
fect around 14 and 40 % of women, respectively, at some
point in their lives. Positive urine culture in the presence
of symptoms is the cornerstone of diagnosis of UTI and
should be performed along with ultrasound assessment of
p o s t v o i dr e s i d u a l( P V R )i na l lw o m e np r e s e n t i n gw i t h
POP and UTI. PVR over 30 mL is an independent risk
factor for UTI, although no specific association with POP
and UTI has been demonstrated. The use of prophylactic
antibiotics remains controversial. The major risk factors
for postoperative UTI are postoperative catheterisation,
prolonged catheterisation, previous recurrent UTI and an
increased urethro-anal distance—suggesting that global
pelvic floor dysfunction may play a role.
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Introduction
Pelvic organ prolapse (POP) and urinary tract infection (UTI)
are common problems. Urinary tract infection (UTI) will
affect around 40 % of women in their lifetime, and a recurrent
UTI will affect around 27 % within the following 6 to
12 months. The annual incidence of surgery for POP is up to
50 cases per 10,000 women-years. This is expected to double
in the next 30 years [1].
A definition for recurrent UTIs is not universally accepted.
Two, three, or four or more [2–4] UTIs in the preceding
12 months are some of the commonest definitions. There
has been no comprehensive study of recurrent UTIs in large
groups, across all ages, or for their relationships and associa-
tions to a wide range of urodynamic and clinical parameters.
In particular, their relationship to POP is not well documented
in the literature despite the common occurrence of these two
entities in older females and the presence of a possible cause
and effect mechanism in some cases.
In the previous literature, the separation of risk factors
f o rr e c u r r e n tU T Ii nw o m e nh a st e n d e dt ob eo nt h eb a s i s
of age. Commonly, three groups are identified: young
premenopausal women, menopausal women between 50
and 70 years, and elderly women. Most studies to date
reflect these patient groups [5].
There are a number of factors associated with young wom-
en and recurrent UTI. Most commonly these are sexual inter-
course [6, 7], which includes a new sexual partner in the
previous 12 months [6]; the use of contraceptives, especially
spermicides, diaphragms and oral contraceptives [6, 8, 9];
family history [10]; and urethro-anal distance (UAD) [11].
The increased susceptibility of women with recurrent UTI to
vaginal colonisation with certain uropathogens compared to
women without recurrent UTI has been the focus of other
studies [12]. The prevalence of recurrent UTI in women who
are non-secretors of ABO blood group antigens has been
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(uropathogenic Escherichia coli have superior adherence to
the uroepithelial cells of non-secreting women, hence an
elevated risk of clinical infection in these women) [13].
Postmenopausal women have a different array of common
risk factors for recurrent UTI. These are UTI history before
menopause, oestrogen deficiency, surgery to the urogenital
region, cystocele, elevated postvoid residual (PVR), and pre-
vious UTI [14, 15]. Cystocele, with its association with ele-
vated PVR, means a number of women with POP will con-
comitantly present with recurrent UTIs. This presents a man-
agementdilemma.Doesthepresenceofprolapsecontributeto
UTI? Will management of the prolapse decrease the risk of
UTI? Is there an associated risk of postoperative UTI? In this
review, we look at the current evidence regarding POP and
associated cystitis or UTI.
What Is POP?
POP affects a significant number of women in the UK,
with anywhere from 11 to 14 % requiring surgical inter-
vention at some point in their lifetimes [16, 17]. The USA
alone performs approximately 200,000 pelvic prolapse
surgical procedures per year [18]. Women may present
with the sensation of dragging or a lump in their vagina,
with sexual dysfunction, or with bladder and/or bowel
dysfunction. In a small number of patients, recurrent UTIs
may be the single presenting complaint.
Proper pelvic floor anatomy and prevention of POP are
reliant upon maintaining the proper anatomical support
mechanisms [19￿￿]. The bony pelvis is composed of two
hip bones connected posteriorly by the sacrum and ante-
riorly by the pubic symphysis. The female pelvis is wider
than in the male so as to accommodate childbirth; how-
ever, this creates a predisposition for pelvic floor weak-
ness. The pelvic diaphragm is composed of the levator ani
and coccygeus muscles. It is the fusion of the posterior
fibres of the pubococcygeus muscles with the
iliococcygeus muscle that forms the levator plate, a struc-
ture between the anus and the coccyx that the pelvic
organs rest upon. Levator ani weakness may lead to a
sagging of the levator plate, which opens the urogenital
hiatus and predisposes to POP [19￿￿]. The endopelvic
fascia is a dense collection of collagen, elastin, smooth
muscle, fibroblasts and vessels that connects the bladder,
urethra, vagina and uterus to the pelvic sidewall [20]. It is
this endopelvic fascia, surrounding the vagina and
connecting laterally to the arcus tendineus fascia, that
provides pelvic sidewall attachment as well as support to
the vaginal walls [21].
Three levels of connective tissue support have been
described for the vagina. Level I support consists of the
uterosacral ligament, connecting the cervix and upper va-
gina. This inserts onto the pelvic sidewall and sacrum. It is
at this level that integrity of the vaginal apex is maintained,
which is now understood to be critically important in
repair. Level II support maintains anterior vaginal func-
tional anatomy. It is composed of the pubocervical fascia
along the length of the vagina. Finally, level III support
maintains distal function and anatomy. This consists of the
perineal membrane, perineal body and the superficial and
deep transverse perineal muscles [19￿￿, 21].
Defects at any of these levels, and usually a combina-
tion of two or all three of them, result in typical anterior
compartment prolapse (cystocele), which may predispose
to UTIs. Rarely, a significant posterior compartment pro-
lapse (rectocele) may press anteriorly on the bladder neck
and urethra causing obstructive voiding, urgency/
frequency and/or elevated postvoid residuals, in turn rais-
ing the possibility of recurrent UTI.
The scope of POP repair is beyond this article, but the
best practice methods are based on restoring normal vag-
inal anatomy to maintain adequate vaginal axis, length
and function (see Table 1). Multiple surgical approaches
have been described, including transvaginal repairs (with
and without mesh), sacrospinous fixation, abdominal
sacrocolpopexy, laparoscopic sacrocolpopexy and robotic
sacrocolpopexy. Regardless of the location of defect, it is
becoming evident that of critical importance for a durable
and effective repair is the adequate fixation of the vaginal
apex. The Surgery for Pelvic Organ Prolapse Committee
has described the apex as the “keystone of pelvic organ
support” and further emphasises that “the best surgical
correction of the anterior and posterior walls may fail
unless the apex is adequately supported” [21, 22, 23￿].
What Is Cystitis?
Broadly, UTI or cystitis is defined as an infection of the
urinary system and may involve the lower urinary tract or
both the lower and upper urinary tracts [24]. It ranges on a
Table 1 Types of prolapse repair by surgical approach
Surgical approach Type of repair
Conservative Ring pessary
Transvaginal approach Anterior colporrhaphy
Posterior colporrhaphy
Mesh repair
Sacrospinous fixation
Abdominal approach Open sacrocolpopexy
Laparoscopic sacrocolpopexy
Robotic sacrocolpopexy
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UTI, to urinary sepsis requiring hospitalisation (see Table 2)
[25, 29￿￿]. Asymptomatic bacteriuria in women is defined as
presence of at least 10
5 CFU/mL of the same uropathogen in
two consecutive clean-catch midstream urine samples obtain-
edfrompatientswithoutanysymptomsorsignsattributableto
urinary infection. Asymptomatic bacteriuria is a state of col-
onisation, not disease, and does not indicate an infection that
requires treatment [26–28].
Establishing a diagnosis of symptomatic UTI requires a
patient to have symptoms and signs of UTI and laboratory
tests confirming the diagnosis (bacteriuria of at least
10
5 CFU/mL and pyuria of at least 10 white blood cells
per high-powered field). Uncomplicated symptomatic UTI
is present when there is a symptomatic bladder infection
manifested by dysuria, worsened urinary frequency or
urgency, fever, suprapubic tenderness, costovertebral an-
gle tenderness with no other cause attributable and labo-
ratory tests revealing UTI [29￿￿]. Fever is usually not
present in symptomatic UTI that is localised to the blad-
der. Complicated UTI is defined as having a symptomatic
UTI in patients caused by a functional or structural ab-
normality, having had urinary instrumentation, having
systemic diseases such as renal insufficiency, diabetes,
or immunodeficiency or having undergone renal trans-
plantation [30–33]. Pyuria is simply defined as the pres-
ence of leukocytes in the urine.
Investigations for UTI
Mostpatients,butnotall,willpresentwithdysuria,frequency,
urgency, nocturia and urge incontinence. Malodorous urine
and haematuria may be present. Very elderly patients, and
patients who are neurologically impaired, may present differ-
ently, and a high level of suspicion should be had for UTI.
Patients who are reliant on self-catheterisation inorder to void
may suffer only from lower abdominal pain or systemic
malaise in the absence of specific lower urinary tract symp-
toms. Fever is uncommon in the first instance but in some
patients will be the only symptom. However, when
superimposedwith a highprevalenceofchronic genitourinary
symptoms, increasing cognitive impairment and a high co-
morbidity load with advancing age, diagnosis and manage-
ment of a symptomatic UTI remains a challenge [29￿￿].
Clinical examination, including the formal examination for
prolapse, should be performed.
The cornerstone of UTI diagnosis is the presence of a
positive urinary culture. For this reason, a urine specimen
should always be sent for microscopy, culture and sensitivity.
Irritative bladder symptoms, not due to infection, must be
ruled out by the presence of a positive urine culture before
the patient is considered to have a UTI. Documented positive
cultures become important when counselling patients as to
whether treatment of their prolapse will have any effect on
their symptoms. Imaging should include ultrasound assess-
ment of the bladder and kidneys, including an assessment of
postvoid residual.
UTI in Association With POP
Haylen et al. conducted an interesting prospective study of
1,140 women presenting for routine urogynaecological as-
sessment due to symptoms of pelvic floor dysfunction. All
patients underwent urodynamic studies [34]. Significant risks
for an increased prevalence of recurrent UTI in women were
found to be nulliparity and a PVR over 30 mL.
This appears to be the first time that nulliparity and recur-
rent UTI have been so clearly linked. A mechanism was
proposed by the authors whereby parity could in fact protect
against recurrent UTIs. As parity increases, number of sexual
partnersmaydecrease.Furthermore,new mothersmaybeless
likely to engage in intercourse due to the stresses that a new
child brings [5–9]. The effect of pregnancy and childbirth on
relaxing and stretching the birth canal may help in preventing
UTIs: if the friction of intercourse has a role in promoting
recurrent UTIs, this would have a lesser impact postpartum
[34]. It is known that sexual histories are difficult to study in a
research context due to the difficulty in obtaining them mak-
ing this theory difficult to prove.
An elevated PVR is another significant factor associat-
ed with recurrent UTIs (over 30 mL). The level of PVR,
described by O’Grady and Cattell, at which UTI becomes
more frequent, was 30 mL [35]. An upper limit of normal
PVR of 30 mL is supported if measured immediately after
Table 2 Types of UTI and their definitions
Condition Definition
Asymptomatic
bacteriuria
Presence of at least 10
5 CFU/mL of the same
uropathogen in two consecutive clean-catch
midstream urine samples obtained from patients
without any symptoms or signs attributable to
urinary infection
Symptomatic UTI Symptoms and signs of UTI and laboratory tests
confirming the diagnosis (bacteriuria of at least
10
5CFU/mLandpyuriaofatleast10whiteblood
cells per high-powered field)
Uncomplicated
UTI
UTIinanormalurinarytractwithoutpriorsurgeryor
instrumentation
Complicated UTI UTI where there is a functional or structural
abnormality, previous urinary instrumentation or
surgery, systemic diseases such as renal
insufficiency, diabetes or immunodeficiency, or
previous renal transplant
Urosepsis Sepsis due to UTI
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ultrasound PVR assessment is therefore recommended for
women with recurrent UTI.
Voiding dysfunction is commonly seen with anterior com-
partment prolapse and is often under-recognised. In the
Haylen paper, women with a final diagnosis of voiding dys-
function had an increased chance of recurrent UTI. This
diagnosis included an assessment of PVR, flow rate and
pressure-flow studies [34]. Up to 39 % of women attending
for assessment of the urogenital tract have been found to have
a preliminarydiagnosis ofvoidingdysfunction,where slowor
incomplete micturition is included as diagnostic criteria [38].
The final diagnosis and the quest for a cause rely upon formal
urodynamic assessment.
Interestingly, in the Haylen paper, no specific associ-
ation with UTI and prolapse was seen. An increasing
negative association between recurrent UTI and prolapse
of higher grade is difficult to explain. The link between
voiding dysfunction and prolapse has been documented
[38]. Despite the link between voiding dysfunction and
recurrent UTI, there is an inverse relationship between
prolapse and recurrent UTI. It is possible that due to the
increased risk of recurrent UTI in nulliparous women
where the stretching effects of childbirth are not found
that this further increases the apparent risk—whereas in
parous women with prolapse, the stretching effects have
obviously been marked, decreasing the UTI risk as
detailed earlier [39].
Postoperative UTI
Aftersurgeryforpelvicorganprolapse(POP) orstressurinary
incontinence (SUI), UTIs are the most common complication
[40, 41]. By the age of 80 years, up to one in nine women will
seek surgery for POP and SUI due to their prevalence in
women [42, 43]. A major trial where autologous sling was
compared to Burch colposuspension for treatment of SUI was
known as the SISTEr trial. In the sling group, 48 % of women
suffered a UTI compared to 32 % in the Burch group during
the first 24 months of follow-up [40]. In a further study in the
Medicare population, where 1,356 sling procedures were
analysed, a UTI developed in 33.6 % of women within
3 months of surgery [44]. When considering obliterative sur-
gery for advanced prolapse in older women, 45 % of women
developed a UTI within 3 months of surgery [41]. This is a
very high occurrence of a significant adverse event for many
women; however, given the instrumentation of the urinary
tract from catheters and cystoscopy inherent in many prolapse
operations, it is understandable. In order to reduce postopera-
tive UTI, targeted strategies are needed. Risk factors that can
be modified need to be identified.
In a case-control study by Sutkin et al., the risk of UTI
within 6 weeks of surgery for POP or SUI was 9.0 % [45￿].
This compares to the SISTEr trial, mentioned above, where
almost17%ofwomenweretreatedforUTIwithin6weeksof
surgery [46]. Two factors, which were found to increase the
risk of UTI postsurgery, were transurethral catheterisation and
incomplete bladder emptying [47]. These findings were in
spite of the use of prophylactic antibiotics.
One of the bladder’s natural mechanical defences against
UTIs is its ability to empty; however, this is compromised by
the transient urinary retention that can occur commonly after
pelvic floor surgery [48, 49] .T h e r ea r ean u m b e ro fc a u s e sf o r
postoperative retention including anaesthesia, swelling and
oedema of tissues, denervation, devascularisation and opioid
use. The subsequent placement of a catheter to empty the
bladder, which is frequently left in situ, is well known to
increase the risk of UTI [50]. In the SISTEr trial, catheterisa-
tion after a failed trial of void resulted in a more than two-fold
increase in risk of UTI [46]. Another study found a more than
four-foldincreaseinriskforpostoperativeUTIinwomenwho
failedatrialofvoidandsubsequentlyhadacatheterplacedfor
more than 10 days [47].
When defining an acceptable trial of void, a commonly
usedrangeofPVRinclinicalpracticeis75–150mL[45￿].For
women with preoperative PVRs greater than 200 mL (and in
some cases much higher), women with severe prolapse, and
for those being discharged on the day of surgery, such a range
may be inappropriate. With a trend towards day of surgery
discharge, the shorter postoperative period may not provide
sufficient time for the resolution of urinary retention. Indeed,
theremaybearushforaclinicaldecisiontobemadeaboutthe
need for catheterisation with a tendency to place a catheter if
there is any doubt, in order to reduce the patient having to re-
present to hospital after hours. This situation therefore pre-
sents a clinical challenge. In order to reduce postoperative
UTI, a balance needs to be found between appropriate but
not overzealous use ofcatheters.Thisshouldbetailoredtothe
individual patient taking into account her age, mobility, type
orsurgical repair, presenceofpreoperativerecurrent UTIsand
preoperative PVRs [51￿￿].
Paradoxically, Sutkin et al. reported that the risk of UTI
wasincreasedbyalargerUAD(adjustedOR1.4).ThePOP-Q
examination, where the genital hiatus and the perineal body
are measured, allowed the hypothesis that a decreased UAD
would increaseenteric colonisationofthe bladder tobetested.
At first thought it appears counterintuitive that increasing the
distance between the exit and entry points of enteric organ-
isms would increase the risk of UTI. However, the authors
proposed that this increased UAD is a surrogate marker for
global pelvic floor neurological and muscular compromise,
which manifests itself as prolapse—descent of the perineum
andpelvis[52].As the neuromuscular compromiseand pelvic
floor dysfunction is unchanged after prolapse surgery, despite
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and UTI development may remain in these women.
There are no studies that we could find in writing this
review that tested the effect of prolapse treatment on reducing
the risk of subsequent UTI. Whilst reducing and repairing
prolapsemayassistinreducingPVR,awell-establishedfactor
inthe developmentofUTIsinthese patients,theroleofglobal
pelvic floor dysfunction should not be discounted. Therefore,
it is likely that surgical treatment of prolapse alone will be
insufficient to prevent UTIs for many women. More research
in this area is warranted.
Postoperative use of prophylactic antibiotics is controver-
sial.RoutineantibioticstopreventUTIinwomenwithasymp-
tomatic bacteriuria associated with catheter use are not gener-
ally recommended [53–56, 57￿￿]. In a randomised trial of
women with suprapubic catheters placed for incomplete emp-
tying after prolapse surgery, nitrofurantoin prophylaxis was
shown to decrease the rate of symptomatic UTIs [58].
Further research to explore urinary acidifiers and other
non-antibiotic measures such as vaginal oestrogens and other
nutriceuticals are required.
Conclusions
POP and UTI are both common problems, causing
considerable morbidity for women. Whilst both prob-
lems occur frequently in isolation, there is a consider-
able cohort of women who suffer from both. Clinical
examination and an ultrasound assessment of PVR
should be performed in all women presenting with pro-
lapse and UTI. Elevated PVR is the most significant
risk factor, linking POP with UTI. The major risk fac-
tors for postoperative UTI are postoperative catheterisa-
tion and prolonged catheterisation, as well as previous
history of recurrent UTI and increased UAD. There is a
need for more evidence on the use of catheters to
manage transient postoperative retention, as well as
more research to find ways of preventing UTI in this
group.
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